Ontology highlight
ABSTRACT:
SUBMITTER: Minoli M
PROVIDER: S-EPMC10113240 | biostudies-literature | 2023 Apr
REPOSITORIES: biostudies-literature
Nature communications 20230418 1
Bladder Cancer (BLCa) inter-patient heterogeneity is the primary cause of treatment failure, suggesting that patients could benefit from a more personalized treatment approach. Patient-derived organoids (PDOs) have been successfully used as a functional model for predicting drug response in different cancers. In our study, we establish PDO cultures from different BLCa stages and grades. PDOs preserve the histological and molecular heterogeneity of the parental tumors, including their multiclonal ...[more]